1 Neuromodulation Devices Market Overview
    1.1 Product Overview and Scope of Neuromodulation Devices
    1.2 Neuromodulation Devices Segment by Type
        1.2.1 Global Neuromodulation Devices Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Deep Brain Stimulation (DBS)
        1.2.3 Spinal Cord Stimulation (SCS)
        1.2.4 Vagus Nerve Stimulation (VNS)
        1.2.5 Sacral Nerve Stimulation (SNS)
        1.2.6 Gastric Electrical Stimulation (GES)
    1.3 Neuromodulation Devices Segment by Application
        1.3.1 Global Neuromodulation Devices Sales Comparison by Application: (2022-2028)
        1.3.2 Pain Management
        1.3.3 Parkinson's Disease
        1.3.4 Urinary and Fecal Incontinence
        1.3.5 Epilepsy
        1.3.6 Gastroparesis
        1.3.7 Other
    1.4 Global Neuromodulation Devices Market Size Estimates and Forecasts
        1.4.1 Global Neuromodulation Devices Revenue 2017-2028
        1.4.2 Global Neuromodulation Devices Sales 2017-2028
        1.4.3 Neuromodulation Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Neuromodulation Devices Market Competition by Manufacturers
    2.1 Global Neuromodulation Devices Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Neuromodulation Devices Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Neuromodulation Devices Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Neuromodulation Devices Manufacturing Sites, Area Served, Product Type
    2.5 Neuromodulation Devices Market Competitive Situation and Trends
        2.5.1 Neuromodulation Devices Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Neuromodulation Devices Players Market Share by Revenue
        2.5.3 Global Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neuromodulation Devices Retrospective Market Scenario by Region
    3.1 Global Neuromodulation Devices Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Neuromodulation Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Neuromodulation Devices Market Facts & Figures by Country
        3.3.1 North America Neuromodulation Devices Sales by Country
        3.3.2 North America Neuromodulation Devices Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Neuromodulation Devices Market Facts & Figures by Country
        3.4.1 Europe Neuromodulation Devices Sales by Country
        3.4.2 Europe Neuromodulation Devices Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Neuromodulation Devices Market Facts & Figures by Region
        3.5.1 Asia Pacific Neuromodulation Devices Sales by Region
        3.5.2 Asia Pacific Neuromodulation Devices Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Neuromodulation Devices Market Facts & Figures by Country
        3.6.1 Latin America Neuromodulation Devices Sales by Country
        3.6.2 Latin America Neuromodulation Devices Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Neuromodulation Devices Market Facts & Figures by Country
        3.7.1 Middle East and Africa Neuromodulation Devices Sales by Country
        3.7.2 Middle East and Africa Neuromodulation Devices Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Neuromodulation Devices Historic Market Analysis by Type
    4.1 Global Neuromodulation Devices Sales Market Share by Type (2017-2022)
    4.2 Global Neuromodulation Devices Revenue Market Share by Type (2017-2022)
    4.3 Global Neuromodulation Devices Price by Type (2017-2022)
5 Global Neuromodulation Devices Historic Market Analysis by Application
    5.1 Global Neuromodulation Devices Sales Market Share by Application (2017-2022)
    5.2 Global Neuromodulation Devices Revenue Market Share by Application (2017-2022)
    5.3 Global Neuromodulation Devices Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Medtronic
        6.1.1 Medtronic Corporation Information
        6.1.2 Medtronic Description and Business Overview
        6.1.3 Medtronic Neuromodulation Devices Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Medtronic Neuromodulation Devices Product Portfolio
        6.1.5 Medtronic Recent Developments/Updates
    6.2 Boston Scientific
        6.2.1 Boston Scientific Corporation Information
        6.2.2 Boston Scientific Description and Business Overview
        6.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Boston Scientific Neuromodulation Devices Product Portfolio
        6.2.5 Boston Scientific Recent Developments/Updates
    6.3 Abbott
        6.3.1 Abbott Corporation Information
        6.3.2 Abbott Description and Business Overview
        6.3.3 Abbott Neuromodulation Devices Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Abbott Neuromodulation Devices Product Portfolio
        6.3.5 Abbott Recent Developments/Updates
    6.4 LivaNova
        6.4.1 LivaNova Corporation Information
        6.4.2 LivaNova Description and Business Overview
        6.4.3 LivaNova Neuromodulation Devices Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 LivaNova Neuromodulation Devices Product Portfolio
        6.4.5 LivaNova Recent Developments/Updates
    6.5 Nevro
        6.5.1 Nevro Corporation Information
        6.5.2 Nevro Description and Business Overview
        6.5.3 Nevro Neuromodulation Devices Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Nevro Neuromodulation Devices Product Portfolio
        6.5.5 Nevro Recent Developments/Updates
    6.6 NeuroPace
        6.6.1 NeuroPace Corporation Information
        6.6.2 NeuroPace Description and Business Overview
        6.6.3 NeuroPace Neuromodulation Devices Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 NeuroPace Neuromodulation Devices Product Portfolio
        6.6.5 NeuroPace Recent Developments/Updates
    6.7 Beijing Pins
        6.6.1 Beijing Pins Corporation Information
        6.6.2 Beijing Pins Description and Business Overview
        6.6.3 Beijing Pins Neuromodulation Devices Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Beijing Pins Neuromodulation Devices Product Portfolio
        6.7.5 Beijing Pins Recent Developments/Updates
    6.8 Synapse Biomedical
        6.8.1 Synapse Biomedical Corporation Information
        6.8.2 Synapse Biomedical Description and Business Overview
        6.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Synapse Biomedical Neuromodulation Devices Product Portfolio
        6.8.5 Synapse Biomedical Recent Developments/Updates
7 Neuromodulation Devices Manufacturing Cost Analysis
    7.1 Neuromodulation Devices Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Neuromodulation Devices
    7.4 Neuromodulation Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Neuromodulation Devices Distributors List
    8.3 Neuromodulation Devices Customers
9 Neuromodulation Devices Market Dynamics
    9.1 Neuromodulation Devices Industry Trends
    9.2 Neuromodulation Devices Market Drivers
    9.3 Neuromodulation Devices Market Challenges
    9.4 Neuromodulation Devices Market Restraints
10 Global Market Forecast
    10.1 Neuromodulation Devices Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Neuromodulation Devices by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Neuromodulation Devices by Type (2023-2028)
    10.2 Neuromodulation Devices Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Neuromodulation Devices by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Neuromodulation Devices by Application (2023-2028)
    10.3 Neuromodulation Devices Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Neuromodulation Devices by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Neuromodulation Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Neuromodulation Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Neuromodulation Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Neuromodulation Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Neuromodulation Devices Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Neuromodulation Devices Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Neuromodulation Devices Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Neuromodulation Devices Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Neuromodulation Devices Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Neuromodulation Devices Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Neuromodulation Devices Manufacturing Sites and Area Served
    Table 11. Manufacturers Neuromodulation Devices Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Neuromodulation Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulation Devices as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
    Table 16. Global Neuromodulation Devices Sales Market Share by Region (2017-2022)
    Table 17. Global Neuromodulation Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Neuromodulation Devices Revenue Market Share by Region (2017-2022)
    Table 19. North America Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
    Table 20. North America Neuromodulation Devices Sales Market Share by Country (2017-2022)
    Table 21. North America Neuromodulation Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Neuromodulation Devices Revenue Market Share by Country (2017-2022)
    Table 23. Europe Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Neuromodulation Devices Sales Market Share by Country (2017-2022)
    Table 25. Europe Neuromodulation Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Neuromodulation Devices Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Neuromodulation Devices Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Neuromodulation Devices Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Neuromodulation Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Neuromodulation Devices Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Neuromodulation Devices Sales Market Share by Country (2017-2022)
    Table 33. Latin America Neuromodulation Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Neuromodulation Devices Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Neuromodulation Devices Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Neuromodulation Devices Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Neuromodulation Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Neuromodulation Devices Revenue Market Share by Country (2017-2022)
    Table 39. Global Neuromodulation Devices Sales by Type (2017-2022) & (K Units)
    Table 40. Global Neuromodulation Devices Sales Market Share by Type (2017-2022)
    Table 41. Global Neuromodulation Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Neuromodulation Devices Revenue Share by Type (2017-2022)
    Table 43. Global Neuromodulation Devices Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Neuromodulation Devices Sales (K Units) by Application (2017-2022)
    Table 45. Global Neuromodulation Devices Sales Market Share by Application (2017-2022)
    Table 46. Global Neuromodulation Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Neuromodulation Devices Revenue Share by Application (2017-2022)
    Table 48. Global Neuromodulation Devices Price by Application (2017-2022) & (USD/Unit)
    Table 49. Medtronic Corporation Information
    Table 50. Medtronic Description and Business Overview
    Table 51. Medtronic Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Medtronic Neuromodulation Devices Product
    Table 53. Medtronic Recent Developments/Updates
    Table 54. Boston Scientific Corporation Information
    Table 55. Boston Scientific Description and Business Overview
    Table 56. Boston Scientific Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Boston Scientific Neuromodulation Devices Product
    Table 58. Boston Scientific Recent Developments/Updates
    Table 59. Abbott Corporation Information
    Table 60. Abbott Description and Business Overview
    Table 61. Abbott Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Abbott Neuromodulation Devices Product
    Table 63. Abbott Recent Developments/Updates
    Table 64. LivaNova Corporation Information
    Table 65. LivaNova Description and Business Overview
    Table 66. LivaNova Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. LivaNova Neuromodulation Devices Product
    Table 68. LivaNova Recent Developments/Updates
    Table 69. Nevro Corporation Information
    Table 70. Nevro Description and Business Overview
    Table 71. Nevro Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Nevro Neuromodulation Devices Product
    Table 73. Nevro Recent Developments/Updates
    Table 74. NeuroPace Corporation Information
    Table 75. NeuroPace Description and Business Overview
    Table 76. NeuroPace Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. NeuroPace Neuromodulation Devices Product
    Table 78. NeuroPace Recent Developments/Updates
    Table 79. Beijing Pins Corporation Information
    Table 80. Beijing Pins Description and Business Overview
    Table 81. Beijing Pins Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Beijing Pins Neuromodulation Devices Product
    Table 83. Beijing Pins Recent Developments/Updates
    Table 84. Synapse Biomedical Corporation Information
    Table 85. Synapse Biomedical Description and Business Overview
    Table 86. Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Synapse Biomedical Neuromodulation Devices Product
    Table 88. Synapse Biomedical Recent Developments/Updates
    Table 89. Production Base and Market Concentration Rate of Raw Material
    Table 90. Key Suppliers of Raw Materials
    Table 91. Neuromodulation Devices Distributors List
    Table 92. Neuromodulation Devices Customers List
    Table 93. Neuromodulation Devices Market Trends
    Table 94. Neuromodulation Devices Market Drivers
    Table 95. Neuromodulation Devices Market Challenges
    Table 96. Neuromodulation Devices Market Restraints
    Table 97. Global Neuromodulation Devices Sales Forecast by Type (2023-2028) & (K Units)
    Table 98. Global Neuromodulation Devices Sales Market Share Forecast by Type (2023-2028)
    Table 99. Global Neuromodulation Devices Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 100. Global Neuromodulation Devices Revenue Market Share Forecast by Type (2023-2028)
    Table 101. Global Neuromodulation Devices Sales Forecast by Application (2023-2028) & (K Units)
    Table 102. Global Neuromodulation Devices Sales Market Share Forecast by Application (2023-2028)
    Table 103. Global Neuromodulation Devices Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 104. Global Neuromodulation Devices Revenue Market Share Forecast by Application (2023-2028)
    Table 105. Global Neuromodulation Devices Sales Forecast by Region (2023-2028) & (K Units)
    Table 106. Global Neuromodulation Devices Sales Market Share Forecast by Region (2023-2028)
    Table 107. Global Neuromodulation Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 108. Global Neuromodulation Devices Revenue Market Share Forecast by Region (2023-2028)
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Neuromodulation Devices
    Figure 2. Global Neuromodulation Devices Market Share by Type in 2021 & 2028
    Figure 3. Deep Brain Stimulation (DBS) Product Picture
    Figure 4. Spinal Cord Stimulation (SCS) Product Picture
    Figure 5. Vagus Nerve Stimulation (VNS) Product Picture
    Figure 6. Sacral Nerve Stimulation (SNS) Product Picture
    Figure 7. Gastric Electrical Stimulation (GES) Product Picture
    Figure 8. Global Neuromodulation Devices Market Share by Application in 2021 & 2028
    Figure 9. Pain Management
    Figure 10. Parkinson's Disease
    Figure 11. Urinary and Fecal Incontinence
    Figure 12. Epilepsy
    Figure 13. Gastroparesis
    Figure 14. Other
    Figure 15. Global Neuromodulation Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Neuromodulation Devices Market Size (2017-2028) & (US$ Million)
    Figure 17. Global Neuromodulation Devices Sales (2017-2028) & (K Units)
    Figure 18. Neuromodulation Devices Sales Share by Manufacturers in 2021
    Figure 19. Global Neuromodulation Devices Revenue Share by Manufacturers in 2021
    Figure 20. The Global 5 and 10 Largest Neuromodulation Devices Players: Market Share by Revenue in 2021
    Figure 21. Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global Neuromodulation Devices Sales Market Share by Region (2017-2022)
    Figure 23. Global Neuromodulation Devices Sales Market Share by Region in 2021
    Figure 24. Global Neuromodulation Devices Revenue Market Share by Region (2017-2022)
    Figure 25. Global Neuromodulation Devices Revenue Market Share by Region in 2021
    Figure 26. U.S. Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Canada Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Germany Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. France Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. U.K. Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Italy Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Russia Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Japan Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. South Korea Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. India Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Australia Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Taiwan Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Indonesia Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Thailand Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Malaysia Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Philippines Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Vietnam Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Mexico Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Brazil Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Argentina Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Turkey Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Saudi Arabia Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. UAE Neuromodulation Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. Sales Market Share of Neuromodulation Devices by Type (2017-2022)
    Figure 51. Manufacturing Cost Structure of Neuromodulation Devices
    Figure 52. Manufacturing Process Analysis of Neuromodulation Devices
    Figure 53. Neuromodulation Devices Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed